Boston Trust Walden’s Carlisle Companies CSL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $658K | Buy |
1,813
+613
| +51% | +$215K | 0.01% | 319 |
|
|
2026
Q1 | $400K | Hold |
1,200
| – | – | ﹤0.01% | 349 |
|
|
2025
Q4 | $384K | Hold |
1,200
| – | – | ﹤0.01% | 345 |
|
|
2025
Q3 | $395K | Hold |
1,200
| – | – | ﹤0.01% | 349 |
|
|
2025
Q2 | $448K | Hold |
1,200
| – | – | ﹤0.01% | 325 |
|
|
2025
Q1 | $409K | Hold |
1,200
| – | – | ﹤0.01% | 324 |
|
|
2024
Q4 | $443K | Hold |
1,200
| – | – | ﹤0.01% | 321 |
|
|
2024
Q3 | $540K | Hold |
1,200
| – | – | ﹤0.01% | 315 |
|
|
2024
Q2 | $486K | Hold |
1,200
| – | – | ﹤0.01% | 322 |
|
|
2024
Q1 | $470K | Hold |
1,200
| – | – | ﹤0.01% | 320 |
|
|
2023
Q4 | $375K | Hold |
1,200
| – | – | ﹤0.01% | 327 |
|
|
2023
Q3 | $311K | Hold |
1,200
| – | – | ﹤0.01% | 330 |
|
|
2023
Q2 | $308K | Hold |
1,200
| – | – | ﹤0.01% | 335 |
|
|
2023
Q1 | $271K | Hold |
1,200
| – | – | ﹤0.01% | 343 |
|
|
2022
Q4 | $283K | Hold |
1,200
| – | – | ﹤0.01% | 341 |
|
|
2022
Q3 | $336K | Hold |
1,200
| – | – | ﹤0.01% | 321 |
|
|
2022
Q2 | $286K | Hold |
1,200
| – | – | ﹤0.01% | 333 |
|
|
2022
Q1 | $295K | Hold |
1,200
| – | – | ﹤0.01% | 350 |
|
|
2021
Q4 | $298K | Hold |
1,200
| – | – | ﹤0.01% | 362 |
|
|
2021
Q3 | $239K | Hold |
1,200
| – | – | ﹤0.01% | 370 |
|
|
2021
Q2 | $230K | Buy |
+1,200
| New | +$223K | ﹤0.01% | 373 |
|
|
2018
Q2 | – | Sell |
-15,500
| Closed | -$1.62M | – | 378 |
|
|
2018
Q1 | $1.62M | Buy |
15,500
+100
| +0.6% | +$11K | 0.02% | 280 |
|
|
2017
Q4 | $1.75M | Hold |
15,400
| – | – | 0.03% | 280 |
|
|
2017
Q3 | $1.54M | Hold |
15,400
| – | – | 0.02% | 292 |
|
|
2017
Q2 | $1.47M | Hold |
15,400
| – | – | 0.02% | 288 |
|
|
2017
Q1 | $1.64M | Buy |
15,400
+4,300
| +39% | +$461K | 0.03% | 276 |
|
|
2016
Q4 | $1.23M | Sell |
11,100
-800
| -7% | -$87.4K | 0.02% | 288 |
|
|
2016
Q3 | $1.22M | Sell |
11,900
-550
| -4% | -$57.4K | 0.02% | 283 |
|
|
2016
Q2 | $1.32M | Sell |
12,450
-775
| -6% | -$78.7K | 0.02% | 281 |
|
|
2016
Q1 | $1.32M | Sell |
13,225
-125
| -0.9% | -$11K | 0.02% | 280 |
|
|
2015
Q4 | $1.19M | Sell |
13,350
-1,475
| -10% | -$130K | 0.02% | 276 |
|
|
2015
Q3 | $1.29M | Sell |
14,825
-6,050
| -29% | -$605K | 0.02% | 278 |
|
|
2015
Q2 | $2.09M | Sell |
20,875
-700
| -3% | -$68.6K | 0.03% | 256 |
|
|
2015
Q1 | $2M | Sell |
21,575
-850
| -4% | -$78.3K | 0.03% | 247 |
|
|
2014
Q4 | $2.02M | Buy |
22,425
+1,000
| +5% | +$86.4K | 0.03% | 247 |
|
|
2014
Q3 | $1.72M | Sell |
21,425
-300
| -1% | -$24.9K | 0.03% | 246 |
|
|
2014
Q2 | $1.88M | Buy |
21,725
+18,725
| +624% | +$1.56M | 0.03% | 239 |
|
|
2014
Q1 | $238K | Sell |
3,000
-100
| -3% | -$7.77K | ﹤0.01% | 316 |
|
|
2013
Q4 | $246K | Hold |
3,100
| – | – | ﹤0.01% | 327 |
|
|
2013
Q3 | $218K | Sell |
3,100
-200
| -6% | -$13.5K | ﹤0.01% | 315 |
|
|
2013
Q2 | $206K | Buy |
+3,300
| New | +$216K | ﹤0.01% | 312 |
|
Other funds holding CSL
VNIM
CB
RS
LWCFA
WF
JIC
RRAM
Boston Trust Walden's CSL Position: Q2 2026 in Review
Boston Trust Walden increased its Carlisle Companies (CSL) stake by 51% in Q2 2026, buying an estimated $215K and bringing the position to 1,813 shares worth $658K. The position accounts for 0.01% of the portfolio, ranked #319.
Boston Trust Walden first reported a position in CSL in Q2 2013 and has held it in 41 quarters since. The position peaked at $2.09M in Q2 2015. 286 funds tracked by Wall St. Rank hold CSL as of Q2 2026.
- Boston Trust Walden held 1,813 shares of Carlisle Companies worth $658K as of Q2 2026.
- Boston Trust Walden bought 613 Carlisle Companies shares in Q2 2026, an estimated $215K.
- Carlisle Companies made up 0.01% of Boston Trust Walden's portfolio in Q2 2026, its #319 holding.
- Boston Trust Walden first reported a position in Carlisle Companies in Q2 2013 and has held it in 41 quarters since.
- Boston Trust Walden's Carlisle Companies position peaked at $2.09M in Q2 2015.
- 286 funds tracked by Wall St. Rank held Carlisle Companies as of Q2 2026.
Based on Boston Trust Walden's 13F filing for Q2 2026, filed 24 Jul 2026.